Maplight Therapeutics, Inc. · NASDAQ:MPLT
Lillie James Woodruff received 7,730 Maplight Therapeutics, Inc. shares as an award (Form 4)
Traded Aug 17, 2026 · Filed Aug 19, 2026
On Aug 17, 2026, Lillie James Woodruff (Chief Scientific Officer) received 7,730 Maplight Therapeutics, Inc. shares as an award, leaving 210,110 shares. Filed Aug 19, 2026 (Form 4).
- Awarded
- 7,730 shares
- Holding after
- 210,110 shares
- Trading plan
- No
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Voting Common Stock | Award | 7,730 | 210,110 | Direct |
Source
Related
- Maplight Therapeutics, Inc.
- Lillie James Woodruff
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Lillie James Woodruff · Oct 16, 2026
- Form 4 · Lillie James Woodruff · Aug 4, 2026
- Form 4 · Lillie James Woodruff · Jul 17, 2026
- Form 4 · Lillie James Woodruff · May 11, 2026
- Form 4 · Lillie James Woodruff · May 6, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026